Yahoo
OTC Markets OTCPK - Delayed Quote USD

Medicine Man Technologies, Inc. (SHWZ)

0.0000 0.0000 (0.00%)
At close: November 4 at 4:00:00 PM EST
Chart Range Bar
Loading chart for SHWZ
  • Previous Close 0.0000
  • Open 0.0022
  • Bid 0.2200 x --
  • Ask 0.2300 x --
  • Day's Range 0.0022 - 0.0022
  • 52 Week Range 0.0000 - 0.0022
  • Volume 3,200
  • Avg. Volume 9,200
  • Market Cap (intraday) 802
  • Beta (5Y Monthly) 365.92
  • PE Ratio (TTM) --
  • EPS (TTM) -0.0000
  • Earnings Date (est.) --
  • Forward Dividend & Yield -- (0.00%)
  • Ex-Dividend Date --
  • 1y Target Est --

Medicine Man Technologies, Inc., doing business as Schwazze, engages in the cultivation, manufacturing, distribution, and retail sale of cannabis and cannabis related products in Colorado and New Mexico. It operates through Retail, Wholesale, and Others segments. The company offers loose flower, concentrates, edibles, pre-rolls, topicals, infused beverages, and other associated cannabis products produced by cannabis vendors; and cannabis and non-cannabis products. It operates retail cannabis dispensaries under the Star Buds, Emerald Fields, Standing Akimbo, Everest Cannabis Co., and R. Greenleaf brand names. In addition, the company sells indoor gardening supplies and hydroponics through its online and retail store. Medicine Man Technologies, Inc. was incorporated in 2014 and is headquartered in Denver, Colorado.

www.schwazze.com

729

Full Time Employees

December 31

Fiscal Year Ends

Healthcare

Sector

Recent News

View More

Performance Overview

Trailing total returns as of 11/5/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SHWZ
99.55%
S&P 500 (^GSPC)
7.42%

1-Year Return

SHWZ
99.55%
S&P 500 (^GSPC)
8.20%

3-Year Return

SHWZ
100.00%
S&P 500 (^GSPC)
68.73%

5-Year Return

SHWZ
100.00%
S&P 500 (^GSPC)
56.54%

Earnings Trends

View More

Earnings Per Share (Normalized)

Revenue vs. Earnings

Annual
Quarterly
Annual
Quarterly
Q2 FY24
Revenue 43.24M
Earnings --
Profit Margin 0.00%

Q3

FY23

Q4

FY23

Q1

FY24

Q2

FY24

0
10M
20M
30M
40M
0.0%

Statistics

View More

Valuation Measures

Annual
  • Market Cap

  • Enterprise Value

  • Trailing P/E

  • Forward P/E

  • PEG Ratio (current)

  • Price/Sales (ttm)

  • Price/Book (mrq)

  • Enterprise Value/Revenue

  • Enterprise Value/EBITDA

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -34.12%

  • Return on Assets (ttm)

    -1.93%

  • Return on Equity (ttm)

    -49.97%

  • Revenue (ttm)

    174.91M

  • Net Income Avi to Common (ttm)

    -67.86M

  • Diluted EPS (ttm)

    -0.0000

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    12.39M

  • Total Debt/Equity (mrq)

    218.30%

  • Levered Free Cash Flow (ttm)

    22.37M

Company Insights

Research Reports

View More

People Also Watch

Mobilize your Website
View Site in Mobile | Classic
Share by: